QSAM Biosciences Announces Submission of IND Application for CycloSam® with FDA
May 04, 2021 09:00 ET
|
QSAM Biosciences Inc.
Austin, TX, May 04, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear medicines for the treatment of cancer and related diseases, announced...